ANDA Suitability for a Change in Dosage Form for Imuran | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2001-P-0452

ANDA Suitability for a Change in Dosage Form for Imuran

Documents

Comments

Description

CLOSED DATE: 12/17/2001 Docket Status: CLOSED

Comment Period OpensJan 28, 2021

Type	Title	Posted	Comments	Status
Other	Approval Letter from FDA CDER to AA1 International	Dec 17, 2001	--

NDA 016-324

50 MG STRENGTH

RHEUMATOID ARTHRITIS

75MG AND 100 MG

RENAL HOMOTRANSPLANTATION

AZATHIOPRINE

125 MG

250 MG

ORAL TABLETS